| Financial Year |
March 31 2022 |
| Monetary Funds |
4,937,541,125.83 |
| Held-for-trading Financial Assets |
774,863,468.01 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,835,778,194.25 |
| Advances to Suppliers |
308,327,943.18 |
| Other Receivables |
1,922,460,904.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,419,206,279.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
199,930,236.26 |
| Total Current Assets |
12,555,022,764.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
369,931,361.15 |
| Investment Properties |
59,988,165.48 |
| Fixed Assetes |
5,539,854,511.24 |
| Under-construction Projects |
763,416,742.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,972,726,486.32 |
| R&D expenses |
26,809,106.71 |
| Goodwill |
1,595,616.68 |
| Long-Term Deferred and Prepaid Expenses |
15,802,305.04 |
| Deferred Income Tax Assets |
50,755,353.86 |
| Other Non-Current Assets |
590,426,774.54 |
| Sub-Total of Non-Current Assets |
10,646,887,886.44 |
| Total Assets |
23,201,910,650.58 |
| Short-Term Loans |
7,497,380,796.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,235,609,618.39 |
| Accounts Payable |
1,278,857,279.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
138,132,328.69 |
| Taxes Payable |
425,595,253.77 |
| Interest Payable |
-- |
| Dividend Payable |
4,642,347.82 |
| Other payables |
600,427,615.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
993,019,634.43 |
| Other Current Liabilities |
5,143,623.87 |
| Sub-Total of Current Liabilities |
12,213,732,487.90 |
| Long-term Loans |
1,004,188,233.37 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
99,887,400.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
104,889,560.81 |
| Deferred Income Tax Liabilities |
29,133,910.80 |
| Other Non-Current Liabilities |
147,854,046.42 |
| Sub-Total of Non-Current Liabilities |
1,620,798,064.33 |
| Total Liabilities |
13,834,530,552.23 |
| Paid-In Capital(Or Share Stock) |
3,013,897,259.00 |
| Capital Surplus |
1,323,668,093.72 |
| Surplus Reserve |
508,629,283.82 |
| LESS:Treasury Stock |
1,010,086,010.59 |
| Undistributed Profits |
5,128,588,660.29 |
| Minority Stockholder's Interest |
398,304,756.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,969,075,342.05 |
| Owner's Equity（Stockholder's Equity） |
9,367,380,098.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,201,910,650.58 |
